Novolog (Pharm-Up 1966) Ltd (NVLG.TA)
ILA 181.1
(0.39%)
ILA 181.1
(0.39%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 200.01 Million | 132.64 Million | 83.38 Million | 58.48 Million | 101.45 Million | 23.96 Million |
| Net Income | -39.38 Million | 51.39 Million | 44.82 Million | 40.56 Million | 10.13 Million | 21.86 Million |
| Depreciation & Amortization | 115.54 Million | 52.85 Million | 45.68 Million | 44.14 Million | 44.16 Million | 21.05 Million |
| Deferred income taxes | 14.47 Million | 1.07 Million | 1.49 Million | -5.95 Million | 12.26 Million | 1.7 Million |
| Stock-based compensation | -155 Thousand | 2.35 Million | 2.58 Million | 3.26 Million | 2.02 Million | 1.48 Million |
| Change in working capital | 106.73 Million | 18.12 Million | -16.56 Million | -29.63 Million | 26.28 Million | -22.58 Million |
| Other non-cash items | 2.79 Million | 6.83 Million | 5.36 Million | 6.1 Million | 6.58 Million | 445 Thousand |
| Investing Cash Flow | -72.6 Million | -124.94 Million | -69.07 Million | -28.6 Million | -59.46 Million | -38.08 Million |
| Investments in PPE | -70.95 Million | -69.49 Million | -30.63 Million | -25.61 Million | -25.01 Million | -29.27 Million |
| Acquisitions | -9.7 Million | -50.9 Million | -19.01 Million | -7.16 Million | -36.54 Million | -8.72 Million |
| Investment purchases | -3.09 Million | -11.93 Million | -26.71 Million | - | - | -500 Thousand |
| Sales/Maturities of investments | 8.63 Million | 5.86 Million | 5.07 Million | - | - | - |
| Other Investing Activities | 2.51 Million | 1.51 Million | 2.22 Million | 4.17 Million | 2.08 Million | 421 Thousand |
| Financing Cash Flow | -67.71 Million | -72.95 Million | 47.48 Million | -39.84 Million | 35.76 Million | -20.37 Million |
| Debt repayment | -23.54 Million | -18.79 Million | -28.97 Million | -65 Thousand | -62 Thousand | -8.84 Million |
| Dividends payments | -16.9 Million | -31.9 Million | -32 Million | -12 Million | -15.49 Million | -8.25 Million |
| Common Stock Repurchased | - | - | - | -22.82 Million | -29.21 Million | - |
| Common Stock Issuance | - | - | 119.83 Million | 33 Thousand | 120.6 Million | -3.84 Million |
| Other Financing Activities | -540 Thousand | -41.05 Million | -40.34 Million | -4.99 Million | -40.07 Million | -8.28 Million |
| Accounts receivables | -242.32 Million | -7.34 Million | -14.65 Million | -8.62 Million | -18.14 Million | -8.33 Million |
| Accounts payables | 242.32 Million | 7.34 Million | 14.65 Million | 8.62 Million | 18.14 Million | - |
| Inventory | -57.43 Million | -2.16 Million | 69.51 Million | -41.09 Million | -33.36 Million | 64.06 Million |
| Other working capital | 164.17 Million | 20.29 Million | -86.07 Million | 11.45 Million | 59.64 Million | -86.64 Million |
| Cash at beginning of period | 172.8 Million | 238.7 Million | 176.44 Million | 185.1 Million | 107.96 Million | 142.38 Million |
| Cash at end of period | 232.93 Million | 172.8 Million | 238.7 Million | 176.44 Million | 185.1 Million | 107.96 Million |
| Capital Expenditure | -70.95 Million | -69.49 Million | -30.63 Million | -25.61 Million | -25.01 Million | -29.27 Million |
| Effect of forex changes on cash | 435 Thousand | -644 Thousand | 463 Thousand | 1.3 Million | -607 Thousand | 77 Thousand |
| Net cash flow / Change in cash | 60.13 Million | -65.9 Million | 62.26 Million | -8.66 Million | 77.13 Million | -34.42 Million |
| Free Cash Flow | 129.05 Million | 63.15 Million | 52.75 Million | 32.87 Million | 76.44 Million | -5.31 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 13.19 Million | 13.23 Million | -43.36 Million | -39.38 Million | 994 Thousand | 12.48 Million |
| Depreciation & Amortization | 16.74 Million | 16.72 Million | 59.2 Million | 115.54 Million | 26.01 Million | 15.31 Million |
| Deferred income taxes | - | - | -2.99 Million | 14.47 Million | -5.73 Million | 1.19 Million |
| Stock-based compensation | 869 Thousand | 870 Thousand | 853 Thousand | -155 Thousand | 582 Thousand | -1.16 Million |
| Change in working capital | 57.73 Million | -48.71 Million | -28.69 Million | 106.73 Million | -33.27 Million | 163.81 Million |
| Other non-cash items | 1.08 Million | 925 Thousand | 647 Thousand | 2.79 Million | -62 Thousand | 717 Thousand |
| Investing Cash Flow | -12.55 Million | -9.97 Million | -14.53 Million | -72.6 Million | -14.23 Million | -18.19 Million |
| Investments in PPE | -12.66 Million | -12.91 Million | -17.59 Million | -70.95 Million | -17.68 Million | -17.84 Million |
| Acquisitions | - | - | 2.99 Million | -9.7 Million | -48 Thousand | -2.94 Million |
| Investment purchases | - | - | - | -3.09 Million | - | - |
| Sales/Maturities of investments | - | - | - | 8.63 Million | - | - |
| Other Investing Activities | 469 Thousand | 863 Thousand | 61 Thousand | 2.51 Million | 3.5 Million | 2.59 Million |
| Financing Cash Flow | -39.94 Million | -9.94 Million | -25.77 Million | -67.71 Million | -8.36 Million | -25.49 Million |
| Debt repayment | -574 Thousand | -287 Thousand | -7.07 Million | -23.54 Million | -285 Thousand | -281 Thousand |
| Dividends payments | -15 Million | - | - | -16.9 Million | - | -16.9 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -14.91 Million | -3.6 Million | -18.69 Million | -540 Thousand | -8.08 Million | -8.31 Million |
| Accounts receivables | -11.01 Million | -78.83 Million | 156.77 Million | -242.32 Million | -158.69 Million | -135.77 Million |
| Accounts payables | - | - | -156.77 Million | 242.32 Million | 158.69 Million | 135.77 Million |
| Inventory | 5.3 Million | 15.32 Million | -23.62 Million | -57.43 Million | 12.19 Million | -41.01 Million |
| Other working capital | 63.45 Million | 14.38 Million | -5.06 Million | 164.17 Million | -45.46 Million | 204.82 Million |
| Cash at beginning of period | 198.92 Million | 232.93 Million | 286.94 Million | 172.8 Million | 320.57 Million | 172.17 Million |
| Cash at end of period | 234.5 Million | 198.92 Million | 232.93 Million | 232.93 Million | 286.94 Million | 320.57 Million |
| Capital Expenditure | -12.66 Million | -12.91 Million | -17.59 Million | -70.95 Million | -17.68 Million | -17.84 Million |
| Effect of forex changes on cash | -324 Thousand | -88 Thousand | 653 Thousand | 435 Thousand | 449 Thousand | -286 Thousand |
| Net cash flow / Change in cash | 35.58 Million | -34.01 Million | -54 Million | 60.13 Million | -33.62 Million | 148.39 Million |
| Free Cash Flow | 75.73 Million | -26.91 Million | -31.93 Million | 129.05 Million | -29.16 Million | 174.51 Million |
6291
LOGC
FCBC
189300
TRITN
OIZ